Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 694.35 INR
Change Today +4.35 / 0.63%
Volume 40.4K
IPCA On Other Exchanges
Symbol
Exchange
Natl India
As of 2:50 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

ipca laboratories ltd (IPCA) Snapshot

Open
690.00
Previous Close
690.00
Day High
695.55
Day Low
684.80
52 Week High
09/12/14 - 829.20
52 Week Low
02/9/15 - 591.25
Market Cap
87.6B
Average Volume 10 Days
139.1K
EPS TTM
20.15
Shares Outstanding
126.2M
EX-Date
07/22/15
P/E TM
34.5x
Dividend
1.00
Dividend Yield
0.14%
Current Stock Chart for IPCA LABORATORIES LTD (IPCA)

Related News

No related news articles were found.

ipca laboratories ltd (IPCA) Related Businessweek News

No Related Businessweek News Found

ipca laboratories ltd (IPCA) Details

Ipca Laboratories Limited manufactures and supplies pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments primarily in India. The company offers APIs in therapeutic areas of anti-malarial, anti-hypertensive, diuretic, anthelmintic, and non steroidal anti-inflammatory drugs. It also provides generic and branded formulations in various dosage forms, such as oral solids and liquids, dry powders for suspension, and liquid and dry injectables. The company provides formulations for cardiovascular, anti-diabetic, cardio-diabetic, rheumatology, orthopedics, pain management, dermatology, gastro-intestinal, anti-bacterial, respiratory, neuropsychiatry, anti-malarial, anti-pyretic, cough, non-steroidal anti-inflammatory drugs, anti-infective, nutraceutical, urology, and geriatric areas, as well as oral and injectable antibiotics surgical and non-surgical needs. In addition, it offers drug intermediates. The company also exports its products to approximately 120 countries worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.

5,051 Employees
Last Reported Date: 05/30/09
Founded in 1949

ipca laboratories ltd (IPCA) Top Compensated Officers

Chairman, Chief Executive Officer, Managing D...
Total Annual Compensation: 33.0M
Chief Financial Officer, Joint Managing Direc...
Total Annual Compensation: 9.7M
President of APIs & Generics, Executive Direc...
Total Annual Compensation: 6.0M
President of Medical Affairs & Clinical Resea...
Total Annual Compensation: --
President of Generics
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

ipca laboratories ltd (IPCA) Key Developments

IPCA Laboratories Limited Declares Dividend, Payable on or Before August 22, 2015

IPCA Laboratories Limited announced that the dividend of INR 1 per share (50%) which if sanctioned will be paid on or before August 22, 2015.

Amyris, Inc. Signs Letter of Intent with Ipca Laboratories Ltd. to Establish an Agreement

Amyris Inc. and Ipca Laboratories Ltd. announced that the companies have signed a Letter of Intent (LOI) to establish an agreement for Amyris to supply a key starting material for an active pharmaceutical ingredient to Ipca. This initial ingredient is expected to enable Ipca to more reliably and cost effectively compete with other manufacturers in the production of one its key pharmaceutical ingredients. It is anticipated that as further developments occur toward the signing of a definitive agreement that both companies will work together on other possible collaborations for additional pharmaceutical ingredients.

Ipca Laboratories Limited, 2015 Earnings Call, Jun 02, 2015

Ipca Laboratories Limited, 2015 Earnings Call, Jun 02, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPCA:IN 694.35 INR +4.35

IPCA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cadila Healthcare Ltd 1,912 INR +32.20
Cipla Ltd/India 705.65 INR +26.10
Lupin Ltd 1,650 INR +10.00
Torrent Pharmaceuticals Ltd 1,447 INR +26.00
Wockhardt Ltd 1,478 INR +14.00
View Industry Companies
 

Industry Analysis

IPCA

Industry Average

Valuation IPCA Industry Range
Price/Earnings 21.6x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 12.7x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IPCA LABORATORIES LTD, please visit www.ipca.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.